Total cholesterol, high density lipoprotein and triglyceride for cardiovascular disease in elderly patients treated with metformin

Archives of Pharmacal Research

Volumn 34, Issue 1, 2011, Pages 99-107

  Sin, Hye Yeon ^a   Kim, Jin Yub ^a   Jung, Ki Hwa ^b  

^a Gangneung Asan Hospital   (South Korea)

^b Duksung Women's University   (South Korea)

Author keywords

Cardiovascular disease; High density lipoprotein cholesterol; Triglyceride

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; PLACEBO; PROTEIN KINASE P60; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLYCEMIC CONTROL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; KOREA; MALE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 79955057045     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0112-5     Document Type: Article

References (28)

1. C. J. Bailey 2008 Metformin: effect on micro and macrovascular complications in type2 diabetes Cardiovasc. Drugs Ther. 22 215 224 18288595 10.1007/s10557-008-6092-0 1:CAS:528:DC%2BD1cXptVKls7o%3D
2. J. A. Beckman M. A. Creager P. Libby 2002 Diabetes and atherosclerosis, epidemiology, pathophysiology, and management JAMA 287 2570 2581 12020339 10.1001/jama.287.19.2570 1:CAS:528:DC%2BD38Xjs1GltLc%3D (Pubitemid 34517204)
3. Bristol-myers squibb company: Glucophage and Glucophage XR prescribing information.available: http://packageinserts.bms.com/pi/pi-glucophage.pdf. accessed July 03 (2009).
4. J. Coresh G. L. Wei G. McQuillan F. L. Brancati A. S. Levey C. Jones M. J. Klag 2001 Prevalence of high blood pressure and elevated serum creatinine level in the United States Arch. Intern. Med. 161 1207 1216 11343443 10.1001/archinte.161.9.1207 1:STN:280:DC%2BD3M3ptFSlsQ%3D%3D
5. M. C. Corti J. M. Guralnik M. E. Salive T. Harris T. S. Field R. B. Wallace L. F. Berkman T. E. Seeman R. J. Glynn C. H. Hennekens R. J. Havik 1995 High density lipoprotein cholesterol predicts coronary heart disease mortality in older persons JAMA 274 539 544 7629981 10.1001/jama.274.7.539 1:CAS:528:DyaK2MXnsFGjsLs%3D
6. B. F. Culleton M. G. Larson J. C. Evans P. W. Wilson B. J. Barrett P. S. Parfrey D. Levy 1999 Prevalence and correlates of elevated serum creatine levels Arch. Intern. Med. 159 1785 1790 10448783 10.1001/archinte.159.15.1785 1:STN:280:DyaK1Mzns1SisQ%3D%3D (Pubitemid 29379143)
7. R. A. DeFronzo A. M. Goodman multicenter metformin study group 1995 Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus N. Engl. J. Med. 333 541 549 7623902 10.1056/NEJM199508313330902 1:CAS:528:DyaK2MXpsVanurY%3D
8. E. Di Angelantonio N. Sarwar S. Kaptoge K. K. Ray A. Thompson A. M. Wood S. Lewington N. Sattar C. J. Packard R. Collins S. G. Thompson J. Danesh 2009 Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 1993 2000 19903920 10.1001/jama.2009.1619
9. B. Hemmingsen S. S. Lund J. Wetterslev A. Vaag 2009 Oral hypoglycemic agent, insulin resistance and cardiovascular disease in patients with type 2 diabetes Eur. J. Endocrinol. 161 1 9 19369429 10.1530/EJE-09-0167 1:CAS:528:DC%2BD1MXovVKktL4%3D
10. Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Hessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stvensen, L. W., and Yancy, C. W., ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. A report of the ACC/AHA task force on practice guideline (trunk), Betheseda (MD). American College of Cardiology foundation (ACCF), August 82p, [694 references] (2005).
11. A. Kooy J. de Jager P. Lehert D. Bets M. G. Wulffelé A. J. Donker C. D. Stehouwer 2009 Long term effect of metformin on metabolism and microvascullar and macrovascular disease Arch. Intern. Med. 169 616 625 19307526 10.1001/archinternmed.2009.20 1:CAS:528:DC%2BD1MXksVOntrY%3D
12. National kidney foundation 2005 K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients Am. J. Kidney Dis. 45 S1 S153
13. B. G. Nordestgaard M. Benn P. Schnohr A. Tybjaerg-Hansen 2007 Non-fasting triglyceride and risk of MI, ischemic heart disease, and death in men and women JAMA 298 299 308 17635890 10.1001/jama.298.3.299 1:CAS:528:DC%2BD2sXotVWmsrk%3D (Pubitemid 47080484)
14. A. D. Pradhan B. M. Everett N. R. Cook N. Rifai P. M. Ridker 2009 Effect of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes JAMA 302 1186 1194 19755697 10.1001/jama.2009.1347 1:CAS:528:DC%2BD1MXhtFCitb3K
15. B. M. Psaty T. Lumley 2008 Surrogate end points and FDA approval JAMA 299 1474 1476 18364491 10.1001/jama.299.12.1474 1:CAS:528:DC%2BD1cXjvVSnsb0%3D (Pubitemid 351468448)
16. N. A. Roper R. W. Bilous W. F. Kelly N. C. Unwin V. M. Connolly 2002 Cause-specific mortality in a population with diabetes Diabetes Care 25 43 48 11772899 10.2337/diacare.25.1.43 (Pubitemid 41070781)
17. Ryden, L., Standl, E., Bartnik, M., Betterridge, J., Van den Berghe, G., de Boer, M. J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., and Thrainsdottir, I., Task force on diabetes cardiovascular diseases guideline on diabetes, pre-diabetes, and cardiovascular disease. Eur. Societ. of Cardiology (ESC), 72p [711 references] (2007).
18. E. Selvin J. Coresh S. H. Golden F. L. Brancati A. R. Folsom M. W. Steffes 2005 Glycemic control and coronary heart disease risk in persons with and without diabetes Arch. Intern. Med. 165 1910 1916 16157837 10.1001/archinte.165.16.1910 (Pubitemid 41352087)
19. E. Selvin S. Bolen H. C. Yeh C. Wiley L. M. Wilson S. S. Marinopoulos L. Feldman J. Vassy R. Wilson E. B. Bass F. L. Brancati 2008 Cardiovascular outcomes in trial of oral diabetes medications Arch. Intern. Med. 168 2070 2080 18955635 10.1001/archinte.168.19.2070
20. R. K. Simmons S. Sharp S. M. Boekholdt L. A. Sargeant K. T. Khaw N. J. Wareham S. J. Griffin 2008 Evaluation of the Framingham risk score in the European prospective investigation of cancer-norfolk cohort Arch. Intern. Med. 168 1209 1216 18541829 10.1001/archinte.168.11.1209 (Pubitemid 351831404)
21. A. D. Sniderman T. Scantlebury K. Cianflone 2001 Hypertriglyceridemic hyperapo B: The unappreciated atherogenic dyslipoproteinemia in tye 2 diabetes mellitus Ann. Intern. Med. 135 447 459 11560458 1:STN:280:DC%2BD3MrislSgtA%3D%3D (Pubitemid 32845869)
22. H. Sone S. Mizuno H. Fujii Y. Yoshimura Y. Yamasaki S. Ishibashi S. Katayama Y. Saito H. Ito Y. Ohashi Y. Akanuma N. Yamada 2005 Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Diabetes Care 28 1463 1471 15920069 10.2337/diacare.28.6.1463 (Pubitemid 40756714)
23. M. P. Stern 1998 The effect of glycemic control on the incidence of macrovascular complications of type2 diabetes Arch. Fam. Med. 7 155 162 9519921 10.1001/archfami.7.2.155 1:STN:280:DyaK1c7nvVOnsQ%3D%3D (Pubitemid 128433237)
24. Summary of revisions for the 2009 2009 clinical practice recommendations Diabetes Care 32 Suppl S3 S5 10.2337/dc09-S003
25. R. C. Turner H. Millns H. A. Neil I. M. Stratton S. E. Manley D. R. Matthews R. R. Holman 1998 Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United kingdom prospective diabetes study (UKPDS23) BMJ 316 823 828 9549452 1:STN:280:DyaK1c3htVKhsg%3D%3D (Pubitemid 28112428)
26. R. C. Turner C. A. Cull V. Frighi R. R. Holman 1999 Glycemic control with diet, sulfonylurea, metformin, or insulin inpatients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 281 2005 2012 10359389 10.1001/jama.281.21.2005 1:CAS:528:DyaK1MXjvFOls7g%3D (Pubitemid 29254858)
27. G. R. Warnick P. D. Wood 1995 National cholesterol education program recommendations for measurement of high-density lipoprotein-cholesterol: executive summary. The national cholesterol education program working group on lipoprotein measurement Clin. Chem. 41 1427 1433 7586512 1:CAS:528: DyaK2MXos1ant74%3D
28. A. W. Weverling-Rijnsburger I. J. Jonkers E. Exel J. Gussekloo R. G. Westendorp 2003 High density vs low density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age Arch. Intern. Med. 163 1549 1554 12860577 10.1001/archinte.163.13.1549 1:CAS:528:DC%2BD3sXmtFGisbk%3D (Pubitemid 36835099)